Hemophilia
- 1 November 1978
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 64 (5) , 75-81
- https://doi.org/10.1080/00325481.1978.11714971
Abstract
The hemophiliac knows when he is bleeding. When such a patient is aware of bleeding and consults a primary care physician, the episode usually has been of sufficient duration and is severe enough to demand prompt treatment with high-potency materials. Needless delay results in further complications and additional costly treatment. The type of deficiency can usually be ascertained from the patient or family member. If there is no history of an inhibitor, replacement therapy should be initiated promptly.Keywords
This publication has 11 references indexed in Scilit:
- Rising Factor VIII Inhibitor Titers after Konȳne Factor IX ComplexNew England Journal of Medicine, 1976
- Immunosuppressive therapy of Factor VIII inhibitorsBlood, 1976
- Intravascular Coagulation with Use of Human Prothrombin Complex ConcentratesAnnals of Internal Medicine, 1976
- Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitorsThe Journal of Pediatrics, 1976
- Measurement of Mild Factor VIII Inhibitors in Bethesda UnitsThrombosis and Haemostasis, 1975
- Efficacy of Self-Therapy in HemophiliaNew England Journal of Medicine, 1974
- Activated Prothrombin Concentrate for Patients with Factor VIII InhibitorsNew England Journal of Medicine, 1974
- Epsilon‐Aminocaproic Acid Therapy for Dental Extractions in Haemophilia and Christmas Disease: A Double Blind Controlled TrialBritish Journal of Haematology, 1971
- Acquired Circulating Anticoagulants in Hemophilia ANew England Journal of Medicine, 1969
- High-potency Antihæmophilic Factor Concentrate prepared from Cryoglobulin PrecipitateNature, 1964